Overview

fluoropyrimidine


'fluoropyrimidine' can also refer to...

fluoropyrimidine

fluoropyrimidine n.

P-0255CARDIAC TOXICITY WITH FLUOROPYRIMIDINES IN COLORECTAL CANCER

Retrospective Analysis of S-1 Monotherapy in Patients with Metastatic Colorectal Cancer After Failure to Fluoropyrimidine and Irinotecan or to Fluoropyrimidine, Irinotecan and Oxaliplatin

Phase II Study of Oxaliplatin in Japanese Patients with Metastatic Colorectal Cancer Refractory to Fluoropyrimidines

Case Report: Hand–Foot Syndrome Induced by the Oral Fluoropyrimidine S-1

P-0086INTRAVENOUS VERSUS ORAL FLUOROPYRIMIDINE: POST GASTRECTOMY CHEMORADIATION WITH JEJUNAL INTERPOSITION RECONSTRUCTION

Incidence of cardiotoxicity with the oral fluoropyrimidine capecitabine is typical of that reported with 5-fluorouracil

A retrospective study of ampullary adenocarcinomas: overall survival and responsiveness to fluoropyrimidine-based chemotherapy†

P-0254TOLERANCE OF RALTITREXED WHEN REPLACING A FLUOROPYRIMIDINE IN COLORECTAL CANCER

Role of interferon as a modulator of fluoropyrimidines: Reply to a recent editorial

Biochemical Modulation of Fluoropyrimidines: Is There an Optimal (6R, S)Leucovorin Dose and Schedule?

A Randomized Phase III trial of Post-operative Adjuvant Oral Fluoropyrimidine versus Sequential Paclitaxel/Oral Fluoropyrimidine; and UFT versus S1 for T3/T4 Gastric Carcinoma: The Stomach Cancer Adjuvant Multi-institutional Trial Group (Samit) Trial

Multicenter Phase II Study of Cetuximab Plus Irinotecan in Metastatic Colorectal Carcinoma Refractory to Irinotecan, Oxaliplatin and Fluoropyrimidines

Oral Fluoropyrimidines (Capecitabine or S-1) and Cisplatin as First Line Treatment in Elderly Patients with Advanced Gastric Cancer: A Retrospective Study

Adjuvant Therapy with Oral Fluoropyrimidines as Main Chemotherapeutic Agents After Curative Resection for Colorectal Cancer: Individual Patient Data Meta-analysis of Randomized Trials

IS4–4HOW TO USE ORAL FLUOROPYRIMIDINE IN TRIPLET OR DOUBLET THERAPY AS THE EUROPEAN STANDARD

Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study

Gefitinib and irinotecan in patients with fluoropyrimidine-refractory, irinotecan-naive advanced colorectal cancer: a phase I–II study

 

More Like This

Show all results sharing this subject:

  • Medicine and Health

GO

Show Summary Details

Quick Reference

n. any one of a class of antimetabolite drugs used in the treatment of gastrointestinal malignancies and breast cancer. They include fluorouracil and the orally administered drugs capecitabine and tegafur/uracil (Uftoral).

Subjects: Medicine and Health.


Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.